As of the latest SEC filings, SUTRO BIOPHARMA, INC. (STRO) is held by 21 institutional funds. The largest fund shareholder is Eventide Healthcare & Life Sciences Fund (ETAHX), holding an estimated $17,818,297.37 in market value, representing 1.12% of its portfolio.
Funds holding SUTRO BIOPHARMA, INC. (STRO)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- STRO
- CIK:
- 0001382101
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
ETAHX
Eventide Healthcare & Life Sciences Fund
|
MF | Independent / Boutique | 1.12% | $17,818,297.37 | 715,307 | Mar 31, 2026 | May 29, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $13,280,118.84 | 533,124 | Mar 31, 2026 | May 28, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.01% | $4,211,359.33 | 169,063 | Mar 31, 2026 | May 28, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.00% | $895,582.97 | 43,751 | Feb 28, 2026 | Apr 24, 2026 |
|
PRFZ
Invesco RAFI US 1500 Small-Mid ETF
|
ETF | Invesco | 0.02% | $628,252.72 | 17,156 | Apr 30, 2026 | Jun 26, 2026 |
|
IWC
iShares Micro-Cap ETF
|
ETF | BlackRock / iShares | 0.04% | $517,056.87 | 20,757 | Mar 31, 2026 | May 28, 2026 |
|
SWTSX
Schwab Total Stock Market Index Fund
|
MF | Charles Schwab | 0.00% | $384,510.00 | 10,500 | Apr 30, 2026 | Jun 25, 2026 |
|
FSKAX
Fidelity Total Market Index Fund
|
MF | Fidelity | 0.00% | $274,645.99 | 13,417 | Feb 28, 2026 | Apr 24, 2026 |
|
VBINX
VANGUARD BALANCED INDEX FUND
|
MF | Vanguard | 0.00% | $232,559.76 | 9,336 | Mar 31, 2026 | May 28, 2026 |
|
FCFMX
Fidelity Series Total Market Index Fund
|
MF | Fidelity | 0.00% | $227,585.46 | 11,118 | Feb 28, 2026 | Apr 24, 2026 |
|
VITNX
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND
|
MF | Vanguard | 0.00% | $219,482.01 | 8,811 | Mar 31, 2026 | May 28, 2026 |
|
GARTX
Goldman Sachs Absolute Return Tracker Fund
|
MF | Goldman Sachs | 0.00% | $101,931.72 | 4,092 | Mar 31, 2026 | May 26, 2026 |
|
FNCMX
Fidelity Nasdaq Composite Index Fund
|
MF | Fidelity | 0.00% | $94,080.12 | 4,596 | Feb 28, 2026 | Apr 24, 2026 |
|
BRSIX
Ultra-Small Company Market Fund
|
MF | Independent / Boutique | 0.06% | $74,730.00 | 3,000 | Mar 31, 2026 | May 21, 2026 |
|
-
TIFF MULTI-ASSET FUND
|
ETF | Independent / Boutique | 0.00% | $37,813.38 | 1,518 | Mar 31, 2026 | Jun 1, 2026 |
|
-
1290 VT Micro Cap Portfolio
|
ETF | Independent / Boutique | 0.02% | $36,866.80 | 1,480 | Mar 31, 2026 | May 26, 2026 |
|
BXMYX
Blackstone Alternative Multi-Strategy Fund
|
MF | Independent / Boutique | 0.00% | $19,180.70 | 770 | Mar 31, 2026 | May 27, 2026 |
|
WCEO
Hypatia Women CEO ETF
|
ETF | Independent / Boutique | 0.20% | $17,064.92 | 466 | Apr 30, 2026 | Jun 26, 2026 |
|
NSGRX
Small Cap Core Fund
|
MF | Independent / Boutique | 0.00% | $6,277.32 | 252 | Mar 31, 2026 | May 28, 2026 |
|
KCEIX
Knights of Columbus U.S. ALL CAP INDEX FUND
|
MF | Independent / Boutique | 0.00% | $1,578.32 | 43 | Apr 30, 2026 | Jun 25, 2026 |
|
BIB
ProShares Ultra Nasdaq Biotechnology
|
ETF | ProShares | 0.00% | $20.47 | 1 | Feb 28, 2026 | Apr 24, 2026 |
Advertisement (320x50)